MediClin Valuation Multiples

Discover MediClin's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Atrys Health, Goodwill Pharma, Clinica Las Condes, Oncoclínicas and more.

MediClin Overview

About MediClin

MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.


Founded

1996

HQ

Germany

Employees

9.8K

Financials (LTM)

Revenue: $914M
EBITDA: $130M

EV

$474M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MediClin Financials

MediClin reported last 12-month revenue of $914M and EBITDA of $130M.

In the same LTM period, MediClin generated $130M in EBITDA and $36M in net income.

Revenue (LTM)


MediClin P&L

In the most recent fiscal year, MediClin reported revenue of $904M and EBITDA of $135M.

MediClin is profitable as of last fiscal year, with gross margin of 84%, EBITDA margin of 15%, and net margin of 3%.

See analyst estimates for MediClin
LTMLast FY202320242025202620272028
Revenue$914M$904M$837M$859M$900M
Gross Profit-$759M$682M$715M$759M
Gross Margin-84%81%83%84%
EBITDA$130M$135M$116M$122M$135M
EBITDA Margin14%15%14%14%15%
EBIT Margin8%7%2%7%7%
Net Profit$36M$29M($12M)$28M$29M
Net Margin4%3%(1%)3%3%

Financial data powered by Morningstar, Inc.

MediClin Stock Performance

MediClin has current market cap of $224M, and enterprise value of $474M.

Market Cap Evolution


MediClin's stock price is $4.73.

MediClin share price increased by 4.5% in the last 30 days, and by 30.4% in the last year.

MediClin has an EPS (earnings per share) of $0.62.

See more trading valuation data for MediClin
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$474M$224M0.9%4.5%19.7%30.4%$0.62

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MediClin Valuation Multiples

MediClin trades at 0.5x EV/Revenue multiple, and 3.6x EV/EBITDA.

See NTM and 2027E valuation multiples for MediClin

EV / Revenue (LTM)


MediClin Financial Valuation Multiples

As of July 17, 2026, MediClin has market cap of $224M and EV of $474M.

MediClin has a P/E ratio of 6.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.5x0.5x0.6x0.6x0.5x
EV/EBITDA3.6x3.5x4.1x3.9x3.5x
EV/EBIT6.9x7.4x35.6x7.9x7.9x
EV/Gross Profit-0.6x0.7x0.7x0.6x
P/E6.2x7.6x(18.2x)7.9x7.7x
EV/FCF6.8x6.3x10.2x11.5x8.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MediClin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MediClin Margins & Growth Rates

MediClin grew revenue by 2% but EBITDA decreased by 3% in the last fiscal year.

In the most recent fiscal year, MediClin reported gross margin of 84%, EBITDA margin of 15%, and net margin of 3%.

See estimated margins and future growth rates for MediClin

MediClin Margins

Last FY202420252026202720282029
Gross Margin84%83%84%-
EBITDA Margin15%14%15%14%
EBIT Margin7%7%7%8%
Net Margin3%3%3%5%
FCF Margin8%5%7%7%

MediClin Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%3%5%2%
Gross Profit Growth-5%6%-
EBITDA Growth(3%)5%10%(3%)
EBIT Growth14%353%(0%)21%
Net Profit Growth45%(331%)3%45%
FCF Growth(13%)(11%)42%11%

Data powered by FactSet, Inc. and Morningstar, Inc.

MediClin Operational KPIs

MediClin's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

MediClin's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MediClin's Rule of X is 20% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for MediClin
LTMLast FY202320242025202620272028
Rule of 4017%17%---
Bessemer Rule of X20%20%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-0%0%0%0%
G&A Expenses to Revenue-2%2%2%2%
Opex to Revenue-77%80%76%78%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Atrys Health2.6x2.5x18.1x15.8x
Goodwill Pharma2.9x-11.1x-
Clinica Las Condes2.7x-(5.9x)-
Oncoclínicas0.8x0.8x6.6x6.4x
Monash IVF Group1.7x1.7x7.4x8.2x
Limes Schlosskliniken3.1x2.7x12.2x10.0x
Pihlajalinna0.6x0.7x3.6x4.0x
Athens Medical Centre1.1x-10.6x-

This data is available for Pro users. Sign up to see all MediClin competitors and their valuation data.

Start Free Trial

Acquisitions by MediClin

MediClin has acquired 1 company to date.

Last acquisition by MediClin was on March 22nd 2024. MediClin acquired Reha-Klinik am Sendesaal for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by MediClin

Reha-Klinik am Sendesaal
Description
Reha-Klinik am Sendesaal is a Duisburg-based interdisciplinary rehabilitation clinic in Germany providing inpatient and outpatient programs in cardiology, orthopedics, and geriatrics. The 120-bed facility offers post-acute care with physiotherapy, occupational therapy, and hydrotherapy in the Rhine-Ruhr region.
HQ CountryGermany
HQ City
Bremen
Deal Date22 Mar 2024
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all MediClin acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MediClin

When was MediClin founded?MediClin was founded in 1996.
Where is MediClin headquartered?MediClin is headquartered in Germany.
How many employees does MediClin have?As of today, MediClin has over 9K employees.
Is MediClin publicly listed?Yes, MediClin is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of MediClin?MediClin trades under MED ticker.
When did MediClin go public?MediClin went public in 2000.
Who are competitors of MediClin?MediClin main competitors include Atrys Health, Goodwill Pharma, Clinica Las Condes, Oncoclínicas, Monash IVF Group, Limes Schlosskliniken, Pihlajalinna, Athens Medical Centre, AirSculpt, Centrum Medyczne ENEL-MED.
What is the current market cap of MediClin?MediClin's current market cap is $224M.
What is the current revenue of MediClin?MediClin's last 12 months revenue is $914M.
What is the current revenue growth of MediClin?MediClin revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of MediClin?Current revenue multiple of MediClin is 0.5x.
What is the current EBITDA of MediClin?MediClin's last 12 months EBITDA is $130M.
What is MediClin's EBITDA margin?MediClin's last 12 months EBITDA margin is 14%.
What is the current EV/EBITDA multiple of MediClin?Current EBITDA multiple of MediClin is 3.6x.
What is the current FCF of MediClin?MediClin's last 12 months FCF is $70M.
What is MediClin's FCF margin?MediClin's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of MediClin?Current FCF multiple of MediClin is 6.8x.
How many companies MediClin has acquired to date?As of July 2026, MediClin has acquired 1 company.
What was the largest acquisition by MediClin?None of the M&A deals MediClin has completed have disclosed valuations.
In how many companies MediClin has invested to date?MediClin hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to MediClin

Lists including MediClin

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial